School of Medicine, Federal University of Minas Gerais CRS

Site Details


Av. Alfredo Balena 190

Room 161

Belo Horizonte, Minas Gerais . 30130-100

Get Directions



CRS Coordinator

Laura Costa


Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.